Showing results (1-10 of 535) with videos related to
Sort By:
Pageof 54
Headache|October 21, 2010
Defining the pharmacologically intractable headache for clinical trials and clinical practiceStephen D Silberstein, David W Dodick, Starr PearlmanDermatologic Clinics|June 30, 2004
Botulinum neurotoxin for the treatment of migraine and other primary headache disordersAndrew M Blumenfeld, David W Dodick, Stephen D SilbersteinHeadache|July 4, 2014
Operational diagnostic criteria for chronic migraine: expert opinionStephen D Silberstein, Richard B Lipton, David W DodickCephalalgia : an International Journal of Headache|December 16, 2014
Late-life migraine accompaniments: A narrative reviewKiratikorn Vongvaivanich, Paweena Lertakyamanee, Stephen D Silberstein, et al.Headache|July 10, 2024
Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trialsStephen D Silberstein, Hans-Christoph Diener, David W Dodick, et al.Cephalalgia : an International Journal of Headache|September 24, 2010
Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility studyJoel R Saper, David W Dodick, Stephen D Silberstein, et al.Headache|April 20, 2005
Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled studyDavid W Dodick, Alexander Mauskop, Arthur H Elkind, et al.Headache|October 21, 2010
Method of injection of onabotulinumtoxinA for chronic migraine: a safe, well-tolerated, and effective treatment paradigm based on the PREEMPT clinical programAndrew Blumenfeld, Stephen D Silberstein, David W Dodick, et al.Pageof 54